Table 1.
Patient characteristics of three cohorts.
| TCGA | GSE17260 | GSE32062 | |
|---|---|---|---|
| Number of patients | 378 | 110 | 260 |
| Age (median, range) | 59 (30–87) | NA | NA |
| Grade (%) | |||
| Grade 1 | 1 (0.26%) | 26 (23.64%) | NA |
| Grade 2 | 45 (11.90%) | 41 (37.27%) | 131 (50.38%) |
| Grade 3 | 321 (84.92%) | 43 (39.09%) | 129 (49.62%) |
| Grade 4 | 1 (0.26%) | NA | NA |
| Unknown | 10 (2.65%) | NA | NA |
| Stage (%) | |||
| I | 1 (0.26%) | NA | NA |
| II | 23 (6.08%) | NA | NA |
| III | 294 (77.78%) | 93 (84.55%) | 204 (78.46%) |
| IV | 57 (15.08%) | 17 (15.45%) | 56 (21.54%) |
| Unknown | 3 (0.79%) | NA | NA |
| Lymphatic invasion | |||
| Yes | 101 (26.72%) | NA | NA |
| No | 48 (12.70%) | NA | NA |
| Unknown | 229 (60.58%) | NA | NA |
| Venous invasion | |||
| Yes | 64 (16.93%) | NA | NA |
| No | 41 (10.85%) | NA | NA |
| Unknown | 273 (72.22%) | NA | NA |
| OS days (median) | 1024 | 915 | 1245 |
OS: overall survival; NA: not applicable.